Stockscreener 앱 받기
57.32
0.48%
-0.53
Bio Techne Corp 주식(TECH)의 최신 뉴스
Snyder Capital Management L P Has $95.64 Million Stake in Bio-Techne Corp $TECH - MarketBeat
TECH Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
TD Asset Management Inc Acquires 36,424 Shares of Bio-Techne Corp $TECH - MarketBeat
Cresset Asset Management Boosts Stake in Bio-Techne - National Today
Cresset Asset Management LLC Increases Position in Bio-Techne Corp $TECH - MarketBeat
Bio-Techne Corp. stock outperforms competitors despite losses on the day - MarketWatch
Bio-Techne at TD Cowen Conference: Strategic Growth and Challenges - Investing.com
TECH Technical Analysis & ETF Price Forecast - Intellectia AI
Segall Bryant & Hamill LLC Sells 34,680 Shares of Bio-Techne Corp $TECH - MarketBeat
Champlain Investment Partners LLC Sells 963,441 Shares of Bio-Techne Corp $TECH - MarketBeat
American Century Companies Inc. Boosts Bio-Techne Stake - National Today
American Century Companies Inc. Grows Stock Position in Bio-Techne Corp $TECH - MarketBeat
3 Reasons to Avoid TECH and 1 Stock to Buy Instead - Finviz
Citigroup Trims Stake in Bio-Techne Corp - National Today
Bio-Techne Corp. Experiences Revision in Stock Evaluation Amid Market Dynamics - Markets Mojo
Bio-Techne Corp. stock underperforms Monday when compared to competitors - MarketWatch
Royce & Associates Cuts Stake in Bio-Techne Corp - National Today
Bio-Techne Corp (TECH) Stock Analysis: Potential 27.54% Upside Amidst Market Challenges - DirectorsTalk Interviews
Bio-Techne Corp $TECH Shares Sold by Royce & Associates LP - MarketBeat
William Blair Investment Management LLC Grows Holdings in Bio-Techne Corp $TECH - MarketBeat
Citigroup Inc. Sells 97,843 Shares of Bio-Techne Corp $TECH - MarketBeat
Tranche Update on Bio-Techne Corporation's Equity Buyback Plan announced on May 6, 2025. - marketscreener.com
Will Ella CE-IVD Approval in EU Clinical Labs Change Bio-Techne's (TECH) Diagnostic Platform Narrative? - Yahoo Finance
Bio-Techne Corp. stock underperforms Friday when compared to competitors despite daily gains - MarketWatch
Bio-Techne Corp $TECH Shares Sold by JPMorgan Chase & Co. - MarketBeat
TECH Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Bio-Techne Corp. stock outperforms competitors on strong trading day - MarketWatch
Bio-Techne Corporation (TECH) Carries Attractive FY27 Organic Growth Projections - Finviz
Bio-Techne to Present at Upcoming Investor Conferences - Finviz
RSI Alert: Bio-Techne (TECH) Now Oversold - Nasdaq
Medpace, Revvity, Azenta, Bio-Techne, and Oscar Health Stocks Trade Down, What You Need To Know - Yahoo Finance
Bio-Techne Corp $TECH Holdings Trimmed by Granite Investment Partners LLC - MarketBeat
OneDigital Investment Advisors LLC Takes Position in Bio-Techne Corp $TECH - MarketBeat
Bio-Techne Corp (NASDAQ:TECH) Receives Consensus Rating of "Moderate Buy" from Analysts - MarketBeat
Aberdeen Group plc Has $499,000 Holdings in Bio-Techne Corp $TECH - MarketBeat
Bio-Techne Corp $TECH Shares Sold by Vanguard Group Inc. - MarketBeat
Bio-Techne Corp $TECH Shares Sold by BNP PARIBAS ASSET MANAGEMENT Holding S.A. - MarketBeat
TECH | Bio-Techne Corp. FinancialsIncome Statement - Quiver Quantitative
17,441 Shares in Bio-Techne Corp $TECH Acquired by Maridea Wealth Management LLC - MarketBeat
Evaluating Bio-Techne (TECH) After Ella’s CE-IVD Milestone And Diagnostics Growth Prospects - Yahoo Finance
Insider plans Rule 144 sale of 1,976 Bio-Techne (TECH) shares - Stock Titan
Bio-Techne (TECH) Gains CE-IVD Certification for Ella Platform i - GuruFocus
Bio-Techne’s Ella platform achieves CE-IVD marking, available for sale in E.U. - TipRanks
Bio-Techne's Ella Immunoassay Platform Receives CE-IVD Marking In EU - Nasdaq
Bio-Techne Corp (TECH): Investor Outlook Highlights 25.56% Potential Upside with Strong Buy Ratings - DirectorsTalk Interviews
Bio-Techne's Ella Platform Achieves CE-IVD Marking Expanding Access to Rapid, Cartridge?Based Immunoassays for European Clinical Laboratories - Investing News Network
Bio-Techne Corp's Ella platform receives CE-IVD marking, available for sale in EU - marketscreener.com
Bio-Techne Corp's Ella Platform Receives CE-Ivd Marking, Available For Sale In EU - TradingView
Fast biomarker test platform gets EU CE-IVD mark for hospital labs - Stock Titan
A | Is Bio Techne Corporation showing insider buyingWeekly Stock Report & Smart Money Movement Tracker - mfd.ru
Why Bio Techne Corporation stock is trending among retail tradersTake Profit & Real-Time Buy Signal Notifications - mfd.ru
ING Groep NV Acquires Shares of 20,266 Bio-Techne Corp $TECH - MarketBeat
Caprock Group LLC Takes $1.71 Million Position in Bio-Techne Corp $TECH - MarketBeat
Principal Financial Group Inc. Sells 35,059 Shares of Bio-Techne Corp $TECH - MarketBeat
Is Bio Techne Corporation (TE1) stock expanding market penetrationJuly 2025 Earnings & Weekly High Potential Alerts - mfd.ru
Bio-Techne Corporation: - marketscreener.com
(TECH) Price Dynamics and Execution-Aware Positioning - Stock Traders Daily
5 Insightful Analyst Questions From Bio-Techne's Q4 Earnings Call - Finviz
There May Be Reason For Hope In Bio-Techne's (NASDAQ:TECH) Disappointing Earnings - Yahoo Finance
What Are Wall Street Analysts' Target Price for Bio-Techne Stock? - Barchart.com
Bio-Techne Announces Changes to its Leadership Team - Investing News Network
Ex-Dividend Reminder: Bio-Techne, 3M and Eli Lilly - Nasdaq
0.50%
자본화:
|
볼륨(24시간):